Did you know that the U.S. NASH Action Plan is the first and only national action plan created to address the growing epidemic of NASH? In 2021, GLI NASH Council partners...
As the world continues to gain a better understanding of COVID-19 and ever present and new variants, Global Liver Institute wants to ensure that we are here to continue to guide, educate, and...
(Washington, D.C., May 3, 2022) – Global Liver Institute (GLI), a premier patient-led liver health nonprofit operating globally, is deeply concerned by the draft opinion published...
(Washington, D.C., April 29, 2022) – As leaders in the liver cancer community, Global Liver Institute and their Liver Cancers team expresses our gratitude and recognizes Dr. Ned Sharpless and...
Welcome to the very first edition of Pediatric & Rare Liver Diseases News! As we expand our offerings for and about this community, Global Liver Institute is also committed to keeping...
Today, April 6, the members of the Liver Action Network (LAN) pledge our collective support for Living Donor Day to honor the donors, recipients, families and caregivers, and clinical teams that...
Transforming Global Consciousness of Liver Health through Education and Advocacy (Washington, D.C., March 30, 2022) – Global Liver Institute (GLI), a patient-led liver health nonprofit...
New Season, New Format: Striving to meet the needs of the expanding liver health- interested community for timely information on must-know events and news specific to our Council communities...
Interested in learning more? Check out what GLI’s President and CEO Donna Cryer, JD has to say on Season 3, Episode 12 of Surfing the NASH Tsunami here. Nonalcoholic steatohepatitis (NASH) has a...
Global Liver Institute Launches Final Nonalcoholic Steatohepatitis (NASH) Externally-Led Patient-Focused Drug Development Meeting Outcome Report (Washington, DC, Wednesday, March 9,...
Recent News
Screening for MASLD is Cost-Effective for PatientsEmerging research continues to shape our understanding of liver health, from cost-effective screening for high-risk MASLD patients to alarming rates of steatosis among young adults without a prior history of fatty...
Terri’s StoryWhen my doctor told me that I had fatty liver disease in 2015, the communication was that it was no big deal. In 2016, I was diagnosed with lupus then pancreatitis. Eventually, the pain, discomfort and fatigue from gallstones led me to an elective...
Why Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver HealthHepatitis C continues to be a significant public health concern with effects that reach beyond liver function. As a physician, you're likely familiar with the chronic health challenges...
Congress goes into recess in October while staff work behind the scenes to prepare for a potentially busy November lame-duck session Congress is in recess with Representatives and Senators back in districts and states connecting with their constituents prior to the...
Cancer Care for the Underrepresented #Octoberis4Livers Welcome back to Liver Cancer News! As we mark Liver Cancer Awareness Month in October, we’re emphasizing the critical role of education and awareness in the fight against liver cancer through the #OctoberIs4Livers...
